Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study).

Sacco RL, Khatri M, Rundek T, Xu Q, Gardener H, Boden-Albala B, Di Tullio MR, Homma S, Elkind MS, Paik MC.

J Am Coll Cardiol. 2009 Dec 8;54(24):2303-11. doi: 10.1016/j.jacc.2009.07.047.

2.

Association between northern Manhattan study global vascular risk score and successful aging.

Warsch JR, Rundek T, Paik MC, Elkind MS, Sacco RL, Wright CB.

J Am Geriatr Soc. 2013 Apr;61(4):519-24. doi: 10.1111/jgs.12166. Epub 2013 Mar 25.

3.

Usefulness of fasting blood glucose to predict vascular outcomes among individuals without diabetes mellitus (from the Northern Manhattan Study).

Eguchi K, Boden-Albala B, Jin Z, Di Tullio MR, Rundek T, Rodriguez CJ, Homma S, Sacco RL.

Am J Cardiol. 2007 Nov 1;100(9):1404-9. Epub 2007 Aug 17.

PMID:
17950798
4.

Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular Endstage Disease) study.

Smink PA, Lambers Heerspink HJ, Gansevoort RT, de Jong PE, Hillege HL, Bakker SJ, de Zeeuw D.

Am J Kidney Dis. 2012 Nov;60(5):804-11. doi: 10.1053/j.ajkd.2012.06.017. Epub 2012 Jul 25.

PMID:
22835901
5.

High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan Study.

Elkind MS, Luna JM, Moon YP, Liu KM, Spitalnik SL, Paik MC, Sacco RL.

Neurology. 2009 Oct 20;73(16):1300-7. doi: 10.1212/WNL.0b013e3181bd10bc.

6.

Belgian global implementation of cardiovascular and stroke risk assessment study: methods and baseline data of the BELGICA-STROKE STUDY.

Van der Niepen P, Thijs V, Devroey D, Fieuw A, Dramaix M, Van de Borne P.

Eur J Cardiovasc Prev Rehabil. 2011 Aug;18(4):635-41. doi: 10.1177/1741826710389416. Epub 2011 Feb 25.

PMID:
21450634
7.
8.

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study.

Assmann G, Cullen P, Schulte H.

Circulation. 2002 Jan 22;105(3):310-5. Erratum in: Circulation 2002 Feb 19;105(7):900.

9.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly..

Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. French.

PMID:
19748369
10.

C-reactive protein in risk prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study.

Tohidi M, Hadaegh F, Harati H, Azizi F.

Int J Cardiol. 2009 Mar 6;132(3):369-74. doi: 10.1016/j.ijcard.2007.11.085. Epub 2008 Feb 1.

PMID:
18242731
11.
12.

Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort.

Heidemann C, Boeing H, Pischon T, Nöthlings U, Joost HG, Schulze MB.

Eur J Epidemiol. 2009;24(6):281-8. doi: 10.1007/s10654-009-9338-7. Epub 2009 Apr 9.

PMID:
19357973
13.

Predictive modeling of health care costs: do cardiovascular risk markers improve prediction?

Baumeister SE, Dörr M, Radke D, Nauck M, John U, Marschall P, Flea S, Schmidt CO, Alte D, Völzke H.

Eur J Cardiovasc Prev Rehabil. 2010 Jun;17(3):355-62. doi: 10.1097/HJR.0b013e328333a0b7.

PMID:
19907337
14.

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

Ridker PM, Buring JE, Rifai N, Cook NR.

JAMA. 2007 Feb 14;297(6):611-9. Erratum in: JAMA. 2007 Apr 4;297(13):1433.

PMID:
17299196
15.

Daytime sleepiness and risk of stroke and vascular disease: findings from the Northern Manhattan Study (NOMAS).

Boden-Albala B, Roberts ET, Bazil C, Moon Y, Elkind MS, Rundek T, Paik MC, Sacco RL.

Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):500-7. doi: 10.1161/CIRCOUTCOMES.111.963801. Epub 2012 Jul 10.

16.

Ideal cardiovascular health predicts functional status independently of vascular events: the Northern Manhattan Study.

Dhamoon MS, Dong C, Elkind MS, Sacco RL.

J Am Heart Assoc. 2015 Feb 12;4(2). pii: e001322. doi: 10.1161/JAHA.114.001322.

17.

Population attributable risks of hypertension and diabetes for cardiovascular disease and stroke in the northern Manhattan study.

Willey JZ, Moon YP, Kahn E, Rodriguez CJ, Rundek T, Cheung K, Sacco RL, Elkind MS.

J Am Heart Assoc. 2014 Sep 16;3(5):e001106. doi: 10.1161/JAHA.114.001106.

18.

Accuracy of anthropometric parameters in identification of high-risk patients predicted with cardiovascular risk models.

Esteghamati A, Mousavizadeh M, Noshad S, Shoar S, Khalilzadeh O, Nakhjavani M.

Am J Med Sci. 2013 Jul;346(1):26-31. doi: 10.1097/MAJ.0b013e31826485de.

PMID:
22986615
19.

Diabetes, fasting glucose levels, and risk of ischemic stroke and vascular events: findings from the Northern Manhattan Study (NOMAS).

Boden-Albala B, Cammack S, Chong J, Wang C, Wright C, Rundek T, Elkind MS, Paik MC, Sacco RL.

Diabetes Care. 2008 Jun;31(6):1132-7. doi: 10.2337/dc07-0797. Epub 2008 Mar 13.

PMID:
18339972
20.

Anthropometric measures and absolute cardiovascular risk estimates in the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study.

Chen L, Peeters A, Magliano DJ, Shaw JE, Welborn TA, Wolfe R, Zimmet PZ, Tonkin AM.

Eur J Cardiovasc Prev Rehabil. 2007 Dec;14(6):740-5.

PMID:
18043293

Supplemental Content

Support Center